GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (LTS:0REN) » Definitions » 3-Year EPS without NRI Growth Rate
中文

Edwards Lifesciences (LTS:0REN) 3-Year EPS without NRI Growth Rate : 11.00% (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Edwards Lifesciences 3-Year EPS without NRI Growth Rate?

Edwards Lifesciences's EPS without NRI for the three months ended in Dec. 2023 was CHF0.55.

During the past 12 months, Edwards Lifesciences's average EPS without NRI Growth Rate was 2.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 11.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Edwards Lifesciences was 28.40% per year. The lowest was 3.50% per year. And the median was 17.20% per year.


Competitive Comparison of Edwards Lifesciences's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, Edwards Lifesciences's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's 3-Year EPS without NRI Growth Rate falls into.



Edwards Lifesciences 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Edwards Lifesciences  (LTS:0REN) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Edwards Lifesciences 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences (LTS:0REN) Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (LTS:0REN) Headlines

No Headlines